Contrave Tablet (Extended Release) (2018-08-06)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| ZNPZ, ZNSC | - Recalling Firm
- Valeant Canada LP
- 2150 St-Elzear Boulevard West,
- Laval
- H7L 4A8
- Quebec
- CANADA
- Marketing Authorization Holder
- Valeant Canada LP
- 2150 St-Elzear Boulevard West,
- Laval
- H7L 4A8
- Quebec
- CANADA
| Contrave Tablet (Extended Release) | Tablet (Extended Release) | DIN 02472945 | Bupropion hydrochloride 90mg |
Recalled Products
Contrave Tablet (Extended Release)
The bottles of affected lots could be perforated.